The association between COVID-19 and cardiac arrhythmias is significant, especially when patients are hit hard by the disease and moved to the ICU. 

The use of conscious sedation during transcatheter aortic valve replacement is associated with better patient outcomes, including a decrease in mortality, than general anesthesia.

Treating atrial fibrillation (AF) patients with catheter ablation is associated with a decreased risk of mortality, heart failure admission and stroke, according to new findings published in the Journal of the American Heart Association.

The Association of Black Cardiologists, American Heart Association and American College of Cardiology have collaborated on a joint statement that touches on the death of George Floyd and its connection to the cardiovascular health of racial minorities in the United States.   

Welldoc, a Columbia, Maryland-based digital health company, has gained an additional FDA approval for its BlueStar diabetes management solution.

Fractional flow reserve guidance can help cardiologists make better decisions during percutaneous coronary intervention—can it lead to better outcomes for patients with stable angina pectoris?

Ticagrelor has been approved by the FDA for reducing the risk of a first heart attack or stroke in high-risk coronary artery disease (CAD) patients.

The FDA is pushing for a voluntary recall of certain lots of extended-release metformin after lab tests revealed unacceptable levels of N-nitrosodimethylamine.

A new study at the University of Cincinnati aims to find out why some TAVR patients experience clotting issues that can lead to substantial side effects.

Non-vitamin K antagonist oral anticoagulants are a valuable treatment option for atrial fibrillation patients with a prior intracranial hemorrhage, according to new findings published in JAMA Network Open.